文献速递免疫规划

TLR2/MyD88在 mice 免疫新孢子虫过程中对特异性IgM和IgG抗体产生的作用

Role of TLR2/MyD88 in the production of specific IgM and IgG antibodies during the immunization of mice against Neospora caninum.
PubMed 文献 · Vaccine · 2022-09-06

研究旨在验证TLR2/MyD88介导应答中的关键分子是否影响小鼠在新孢子虫可溶性抗原免疫过程中特异性IgM和IgG抗体的产生。结果显示,缺乏IFN-γ未对特异性抗体产生造成负面影响,但TLR2、MyD88、IL-12和诱导型一氧化氮合酶基因缺陷小鼠针对新孢子虫抗原的抗体水平显著降低,且血清识别的抗原多样性也相应改变。

要点

  • 缺乏IFN-γ未对小鼠特异性抗体产生造成负面影响。
  • TLR2、MyD88、IL-12和iNOS缺陷小鼠抗体水平显著降低。
  • 上述基因缺陷也反映在血清识别的抗原多样性改变上。

核心结论

  • TLR2/MyD88固有识别通路中的分子可能对针对新孢子虫的抗体应答诱导产生直接影响。

研究设计与样本

  • 研究旨在验证TLR2/MyD88介导应答中的关键分子是否影响小鼠在新孢子虫可溶性抗原免疫过程中特异性IgM和IgG抗体的产生。

主要发现

  • 缺乏IFN-γ未对特异性抗体产生造成负面影响。
  • TLR2、MyD88、IL-12和诱导型一氧化氮合酶基因缺陷小鼠针对新孢子虫抗原的抗体水平显著降低。
  • 上述抗体水平降低也反映在血清识别的抗原多样性改变上。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neospora caninum is a parasite relevant to the veterinary field. Innate and adaptive responses against N. caninum induce effector mechanisms that limit parasite replication, but little is known about their role in humoral response. Our work aimed to verify whether key molecules in the TLR2/MyD88-mediated response would impact the production of specific IgM and IgG antibodies in mice during immunization with soluble antigens of N. caninum. We observed that lack of IFN-gamma did not negatively affect the production of specific antibodies. However, mice genetically deficient in Toll-like receptor 2, Myeloid differentiation factor 88, Interleukin 12 and inducible nitric oxide synthase presented significant decrease in antibody levels against N. caninum antigens, which also reflected in the diversity of the antigen recognized by their serum. In that sense, we show here that molecules within this innate recognition pathway may present a direct impact in the induction of an antibody response against N. caninum.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ferreira Silva M, Salomão Lopes C, Batista Ferreira França F, et al. Role of TLR2/MyD88 in the production of specific IgM and IgG antibodies during the immunization of mice against Neospora caninum. Vaccine. 2022. PMID: 36075796. doi:10.1016/j.vaccine.2022.08.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。